Viewing Study NCT04284202


Ignite Creation Date: 2025-12-25 @ 4:01 AM
Ignite Modification Date: 2026-01-28 @ 5:11 PM
Study NCT ID: NCT04284202
Status: UNKNOWN
Last Update Posted: 2020-02-25
First Post: 2020-02-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: PD-1 Combined With Dasatinib for as Third-line Treatment for ARID1A Mutation Advanced NSCLC
Sponsor: The Affiliated Hospital of Qingdao University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module